Thursday, October 27, 2011

AstraZeneca gets the cash out to shareholders, chump change to Seroquel diabetes lawsuit victims: $ 759 million spent in legal defense

Business as usual at AstraZeneca

AstraZeneca PLC  Third  Q 2011

What a relief! AstraZeneca shareholders gain while the injured Seroquel plaintiffs wait for their chump change settlement checks, which are no where in sight.

What would a day at AstraZeneca be like if there wasn't a subpoena from the Department of Justice?

"On 5 October 2011, AstraZeneca LP and AstraZeneca Pharmaceuticals LP received a subpoena from the Department of Justice in connection with an investigation of the possible submission of false or otherwise improper pricing information to the Centers for Medicare and Medicaid Services. The precise parameters of this inquiry are unknown, and AstraZeneca is not in a position at this time to predict the scope, duration or outcome of this matter, including whether it will result in any liability to AstraZeneca. "

What would a day at AstraZeneca be like without a little unethical business practice?

Serbian Doctors recipients of alleged improper payments from AstraZeneca

"In August 2011, AstraZeneca UK Limited’s Representative Office in Belgrade, Serbia was served with a criminal indictment relating to allegations that local employees of AstraZeneca made allegedly improper payments to physicians at the Institute of Oncology and Radiology of Serbia.  AstraZeneca has filed a number of preliminary procedural objections, which ask the Serbian criminal court to dismiss the indictment against the Representative Office."

No comments:

Post a Comment

Please be civil, agree to disagree, and express your opinion. Comments will be moderated for content to avoid inflammatory language and spam